Multiplex Biomarker Imaging Market to Reach $523.59 Mn by 2023: Thermo Fisher Scientific, Merck, Illumina, Abcam, Perkin Elmer, US Biomax

The different aspects of data on the Multiplex Biomarker Imaging market critical data are showcased intellectually through resources such as infographics, charts, and tables.

Logo

New York, NY -- (SBWire) -- 07/11/2019 --The multiplex biomarker imaging market will grow because of its ability to detect the presence of, severity, and exact location of chronic diseases and tumors, along with other applications. According to Netscribes, the global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018-2023 period, generating a revenue of USD 523.59 Mn by 2023.

Get Free Sample Copy Here@ https://www.marketexpertz.com/sample-enquiry-form/43412

The major players in the Multiplex Biomarker Imaging market are
- Thermo Fisher Scientific, Inc.
- Perkin Elmer, Inc.
- Abcam Plc.
- Bio-Rad Laboratories Inc.
- US Biomax, Inc.
- Merck KGaA
- Ventana Medical Systems, Inc.
- MicroConstants, Inc.
- Leica Biosystems Nussloch GmbH
- ToposNomos Ltd.
- Illumina, Inc.

Major Regions play vital role in Multiplex Biomarker Imaging market are:
- North America
- Europe
- China
- Japan
- Middle East & Africa
- India
- South America
- Others

We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Buy Now @ https://www.marketexpertz.com/checkout-form/43412

The global multiplex biomarker imaging market can be segmented based on:
o Techniques - immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), immunofluorescence (IF), tissue microarray (TMA), and toponome imaging system (TIS)
o Components - instruments, reagents and kits, and software
o Applications - oncology studies, drug safety, genetic characterization, and others (neurodegeneration and protein research)
o End users - research institutes, translational labs, and pharma and biopharma companies

Key Stakeholders
- Multiplex Biomarker Imaging Manufacturers
- Multiplex Biomarker Imaging Distributors/Traders/Wholesalers
- Multiplex Biomarker Imaging Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
- Available Customizations

You Can Get Free Sample According To The Report @
https://www.marketexpertz.com/sample-enquiry-form/43412

Application segment insights:
Multiplex biomarker imaging products are used mostly in oncology studies. This will be followed by drug safety applications, which is expected to expand at a CAGR of 14.1% during 2018-2023.
End user segment insights:
Currently, multiplex biomarker imaging products can only be used for research purposes. Pharma and biopharma companies dominated the market's end user segment in 2017 with a share of 39%. Meanwhile, translational laboratories are projected to grow at a significant rate during the forecast period.

Technique segment insights:
IHC held the largest market share (around 47%) in this segment in 2017. It is widely used in research laboratories and clinical diagnostics, owing to the advantages it offers, vis--vis traditional methods of enzyme staining, including specific antigen-antibody reactions. Higher incidence of chronic diseases, especially cancer, is fuelling the need for targeted treatments, thereby contributing to the growth of TMA. The market for TMA is projected to expand at a CAGR of 14.3% during the 2018-2023 period.

Component segment insights:
The instruments section held the largest market share (67%) in 2017, followed by reagents and kits. However, software is predicted to record the fastest expansion (CAGR of 15.0%) during the forecast period (2018-2023), with more automated software packages being made available to researchers. These software modules assist in the research of various diseases and improve the workflow of quantitative analysis.

Browse The Report Description@ https://www.marketexpertz.com/industry-overview/multiplex-biomarker-imaging-market

About MarketExpertz
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:
John Watson
Head of Business Development
Market Expertz | Web: www.marketexpertz.com
Direct Line: +1-800-819-3052
E-mail: sales@marketexpertz.com
News: www.marketexpertz.com/market-news

Media Relations Contact

John Watson
1-800-819-3052
https://www.marketexpertz.com/

View this press release online at: http://rwire.com/1245786